Search

Home > Lung Cancer Considered > From the Basics to Next Line Therapy: ALK + NSCLC
Podcast: Lung Cancer Considered
Episode:

From the Basics to Next Line Therapy: ALK + NSCLC
Category: Science & Medicine
Duration: 00:46:09
Publish Date: 2024-02-27 14:00:02
Description: ALK fusions represent 3-5% of newly diagnosed non-small cell lung cancers but several therapeutic options do exist. Lung Cancer Considered host Dr. Narjust Florez and guests Dr. Christine Lovly from Vanderbilt University and Yvonne Diaz from Oncogene Cancer Research discuss how an ALK positive diagnosis is made and what therapies are currently available to treat it.
Total Play: 0